A Kansas City man sued DePuy Synthes, Johnson & Johnson s orthopedic company, alleging the company s artificial hip was faulty and required a complex revision surgery, Kansas City Business Journal reported Dec. 11.
Endeavor Orthopaedics has appointed Jon Holder as chair of the board of directors and Greg Parranto as CEO. Holder brings orthopedic startup and strategic sales
GSK took Blenrep off the market last year after the multiple myeloma drug failed its confirmatory study. But GSK now says it has interim data showing Blenrep beat a blockbuster Johnson & Johnson drug in a head-to-head Phase 3 study testing it as an earlier line of therapy.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).